Huntsman (NYSE:HUN – Get Free Report) announced its earnings results on Thursday. The basic materials company reported ($0.06) EPS for the quarter, meeting analysts’ consensus estimates of ($0.06), RTT News reports. Huntsman had a net margin of 1.65% and a return on equity of 1.92%. The firm had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the previous year, the business posted $0.20 EPS. The company’s quarterly revenue was down 8.5% on a year-over-year basis.
Huntsman Stock Performance
Shares of Huntsman stock traded up $0.51 during trading hours on Thursday, reaching $24.33. 3,033,333 shares of the stock traded hands, compared to its average volume of 1,950,564. The company has a 50 day moving average price of $25.19 and a 200 day moving average price of $24.66. The firm has a market capitalization of $4.21 billion, a price-to-earnings ratio of 45.91 and a beta of 1.14. Huntsman has a one year low of $22.14 and a one year high of $29.90. The company has a quick ratio of 1.23, a current ratio of 1.97 and a debt-to-equity ratio of 0.48.
Huntsman Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were given a $0.25 dividend. This is a positive change from Huntsman’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $1.00 dividend on an annualized basis and a yield of 4.11%. Huntsman’s payout ratio is 188.68%.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Huntsman
Huntsman Company Profile
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Featured Articles
- Five stocks we like better than Huntsman
- Health Care Stocks Explained: Why You Might Want to Invest
- Meta Stock: 3 Reasons This Stumble Is a Golden Buying Opportunity
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Staples Stocks to Cushion Lower Consumer Sentiment
- Technology Stocks Explained: Here’s What to Know About Tech
- Zillow’s Earnings Dip: An Opportunity for Visionaries
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.